Literature DB >> 27291331

Epidemiological and clinical scenario of chronic liver diseases in Italy: Data from a multicenter nationwide survey.

Evangelista Sagnelli1, Tommaso Stroffolini2, Caterina Sagnelli3, Antonina Smedile4, Filomena Morisco5, Caterina Furlan2, Sergio Babudieri6, Giuseppina Brancaccio7, Nicola Coppola8, Giovanni Battista Gaeta7, Piero Luigi Almasio9.   

Abstract

BACKGROUND: The last Italian prevalence survey on chronic liver diseases (CLD) was performed in 2001. The present study evaluated the changes occurring over thirteen years.
METHODS: We enrolled 2,557 CLD consecutive patients in 16 Italian liver units in 2014.
RESULTS: HBV etiology accounted for 513 (20.2%) cases, alone in 439 and associated with HCV and/or alcohol abuse in 74. Of these 513, 11.9% were anti-HDV-positive and 7.2% HBeAg-positive. HCV alone was responsible for 50.3% of CLD and with alcohol abuse for 5.9%. HCV RNA was detected in 64.0% of the anti-HCV-positive patients tested. HCV genotyping, performed for 899 patients, showed genotype-1a, 1b, 2, 3, 4 and 5 respectively in 16.5%, 45.5%, 15.4%, 8.2%, 15.1% and 0.2%. Alcohol abuse alone was responsible for 6.4% of cases and NAFLD/NASH for 6.3%. Liver cirrhosis (p<0.001) and HCC (p<0.001) were more frequent in alcoholic than viral etiologies. HCV and alcohol etiologies were more frequent in 2001 than 2014 (from 69.9% to 59.9% and from 23.0% to 12.3%, respectively). HBV showed a similar impact. In all etiologies, the 2001 CLD cases were 10 years younger and with a significantly lower rate of cirrhosis than the 2014 cases.
CONCLUSION: The changes in HCV, HBV and alcohol etiologies may help apply more appropriate healthcare strategies.
Copyright © 2016 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chronic hepatitis; Chronic liver diseases; HCC; Liver cirrhosis

Mesh:

Year:  2016        PMID: 27291331     DOI: 10.1016/j.dld.2016.05.014

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  9 in total

1.  Gender differences in chronic liver diseases in two cohorts of 2001 and 2014 in Italy.

Authors:  Evangelista Sagnelli; Tommaso Stroffolini; Caterina Sagnelli; Mario Pirisi; Sergio Babudieri; Guido Colloredo; Maurizio Russello; Nicola Coppola; Giovanni Battista Gaeta; Bruno Cacopardo; Massimo De Luca; Piero Luigi Almasio
Journal:  Infection       Date:  2017-11-17       Impact factor: 3.553

2.  Mitochondrial carnitine palmitoyl transferase-II inactivity aggravates lipid accumulation in rat hepatocarcinogenesis.

Authors:  Juan-Juan Gu; Min Yao; Jie Yang; Yin Cai; Wen-Jie Zheng; Li Wang; Deng-Bing Yao; Deng-Fu Yao
Journal:  World J Gastroenterol       Date:  2017-01-14       Impact factor: 5.742

3.  Hepatitis B virus infection in undocumented immigrants and refugees in Southern Italy: demographic, virological, and clinical features.

Authors:  Nicola Coppola; Loredana Alessio; Luciano Gualdieri; Mariantonietta Pisaturo; Caterina Sagnelli; Carmine Minichini; Giovanni Di Caprio; Mario Starace; Lorenzo Onorato; Giuseppe Signoriello; Margherita Macera; Italo Francesco Angelillo; Giuseppe Pasquale; Evangelista Sagnelli
Journal:  Infect Dis Poverty       Date:  2017-02-09       Impact factor: 4.520

4.  Sex difference in the interaction of alcohol intake, hepatitis B virus, and hepatitis C virus on the risk of cirrhosis.

Authors:  Tommaso Stroffolini; Evangelista Sagnelli; Angelo Andriulli; Guido Colloredo; Caterina Furlan; Giovanni Battista Gaeta; Filomena Morisco; Mario Pirisi; Floriano Rosina; Caterina Sagnelli; Antonina Smedile; Piero Luigi Almasio
Journal:  PLoS One       Date:  2017-11-15       Impact factor: 3.240

5.  Clinical epidemiology of chronic viral hepatitis B: A Tuscany real-word large-scale cohort study.

Authors:  Cristina Stasi; Caterina Silvestri; Roberto Berni; Maurizia Rossana Brunetto; Anna Linda Zignego; Cristina Orsini; Stefano Milani; Liana Ricciardi; Andrea De Luca; Pierluigi Blanc; Cesira Nencioni; Donatella Aquilini; Alessandro Bartoloni; Giampaolo Bresci; Santino Marchi; Franco Filipponi; Piero Colombatto; Paolo Forte; Andrea Galli; Sauro Luchi; Silvia Chigiotti; Alessandro Nerli; Giampaolo Corti; Rodolfo Sacco; Paola Carrai; Angelo Ricchiuti; Massimo Giusti; Paolo Almi; Andrea Cozzi; Silvia Carloppi; Giacomo Laffi; Fabio Voller; Francesco Cipriani
Journal:  World J Hepatol       Date:  2018-05-27

Review 6.  Eradication of HCV Infection with the Direct-Acting Antiviral Therapy in Renal Allograft Recipients.

Authors:  Armando Calogero; Evangelista Sagnelli; Massimiliano Creta; Silvia Angeletti; Gaia Peluso; Paola Incollingo; Maria Candida; Gianluca Minieri; Nicola Carlomagno; Concetta Anna Dodaro; Massimo Ciccozzi; Caterina Sagnelli
Journal:  Biomed Res Int       Date:  2019-04-07       Impact factor: 3.411

7.  High Rates of Hidden HCV Infections among Hospitalized Patients Aged 55-85.

Authors:  Annarita Valeria Piazzolla; Giulia Paroni; Francesca Bazzocchi; Mauro Cassese; Antonio Cisternino; Luigi Ciuffreda; Franco Gorgoglione; Leonardo Gorgoglione; Vincenzo Palazzo; Natale Sciannamè; Marco Taurchini; Pasquale Vaira; Giovanna Cocomazzi; Maria Maddalena Squillante; Filippo Aucella; Nicola Cascavilla; Salvatore De Cosmo; Michelantonio Fania; Antonio Greco; Antonio Laborante; Maurizio Leone; Evaristo Maiello; Mauro Salvatori; Lazzaro Di Mauro; Alessandra Mangia
Journal:  Pathogens       Date:  2021-06-03

8.  Prevalence of Hepatitis B, C, and D in Germany: Results From a Scoping Review.

Authors:  Ida Sperle; Gyde Steffen; Siv Aina Leendertz; Navina Sarma; Sandra Beermann; Roma Thamm; Yanita Simeonova; Markus Cornberg; Heiner Wedemeyer; Viviane Bremer; Ruth Zimmermann; Sandra Dudareva
Journal:  Front Public Health       Date:  2020-08-28

9.  Characteristics and Changes over Time of Alcohol-Related Chronic Liver Diseases in Italy.

Authors:  Tommaso Stroffolini; Evangelista Sagnelli; Caterina Sagnelli; Filomena Morisco; Sergio Babudieri; Caterina Furlan; Mario Pirisi; Maurizio Russello; Antonina Smedile; Mariantonietta Pisaturo; Piero Luigi Almasio
Journal:  Can J Gastroenterol Hepatol       Date:  2018-09-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.